A major new systematic review has concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental...
Few conditions in the field of medical cannabis are backed by such adamant patient conviction, but as little clinical data...
Written by Ben Stevens & Sarah Sinclair A new campaign is calling for urgent regulatory changes to how medical cannabis...
In our latest Beyond the Abstract, we dive into cannabis use and its impact on mental health, a controversial and...
Welcome to Business of Cannabis’ new research digest, unpacking the latest clinical evidence shaping cannabis therapeutics. While headlines often focus...
Scrutiny of the UK’s medical cannabis industry has rarely, if ever, been so acute since it was legalised in 2018. ...
President Donald Trump’s executive order directing federal agencies to move cannabis from Schedule I to Schedule III of the Controlled...
From the Editor If you’re reading this, then congratulations! We have reached the end of a very long road together....
